menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Emil Kakkis, MD, PhD
Emil Kakkis, MD, PhD

    Dr. Emil D. Kakkis is an advisor for BioMarin Pharmaceutical Inc. since March 2009; he has served in a number of capacities, including chief medical officer and senior vice president, since 1998. Dr. Kakkis developed Aldurazyme, a recombinant form of alpha-L-iduronidase, the enzyme deficient in MPS I patients.

    From July 1994 to August 1998, Dr. Kakkis was an assistant professor of the Harbor-UCLA Medical Center, division of genetics, department of pediatrics. Dr. Kakkis is the author of numerous published articles and abstracts on MPS I and alpha-L-iduronidase. He holds an MD and a PhD in biological chemistry from the Medical Scientist Training Program at the UCLA School of Medicine. Dr. Kakkis completed a fellowship in genetics at the UCLA Intercampus Medical Genetics training program and, prior to that, conducted his pediatric residency at the Harbor-UCLA Medical Center; he is board-certified in pediatrics and medical genetics.

    Schedule29 Mar 2024